Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansen, L. A.
Right arrow Articles by Terry, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansen, L. A.
Right arrow Articles by Terry, R. D.
NEUROLOGY 1988;38:48
© 1988 American Academy of Neurology

Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease

Lawrence A. Hansen, MD, Richard DeTeresa, BS, Peter Davies, PhD and Robert D. Terry, MD

Departments of Neurosciences (Dr. Hansen, Mr. DeTeresa, and Dr. Terry) and Pathology (Dr. Terry), School of Medicine, University of California, San Diego, La Jolla, CA; and the Department of Pathology (Dr. Davies), Albert Einstein College of Medicine, Bronx, NY.

We studied neocortical morphometry (cortical thickness, neurons, and glia), lesion counts (plaques and tangles), and choline acetyltransferase levels in up to 113 Alzheimer brains and 48 controls. Comparisons between young (under 65) and old (over 70) Alzheimer cases revealed more tangles in the former, but no other statistically significant differences in the measured variables. Differences in these parameters between young Alzheimer cases and young controls were similar to the differences found between old Alzheimer cases and old controls. Linear regression analyses correlating some of these variables with age in Alzheimer's disease, considered together with the effects of normal aging on the same parameters, reveal in Alzheimer's disease a spectrum of graded pathologic severity inversely proportional to age. Nevertheless, even in advanced old age (80 to 100), significant differences persist in these parameters between very elderly Alzheimer brains and controls.

Address correspondence and reprint requests to Dr. Terry, Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla, CA 92093.

Supported by NIH Grants AGO5386, AGO5131, and by the McKnight Foundation.

Received December 1, 1986. Accepted for publication in final form March 11, 1987.




This article has been cited by other articles:


Home page
BrainHome page
D. G. Harper, E. G. Stopa, V. Kuo-Leblanc, A. C. McKee, K. Asayama, L. Volicer, N. Kowall, and A. Satlin
Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia
Brain, June 1, 2008; 131(6): 1609 - 1617.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
G. A. Marshall, L. A. Fairbanks, S. Tekin, H. V. Vinters, and J. L. Cummings
Early-Onset Alzheimer's Disease Is Associated With Greater Pathologic Burden
J Geriatr Psychiatry Neurol, March 1, 2007; 20(1): 29 - 33.
[Abstract] [PDF]


Home page
BrainHome page
V. Singh, H. Chertkow, J. P. Lerch, A. C. Evans, A. E. Dorr, and N. J. Kabani
Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease
Brain, November 1, 2006; 129(11): 2885 - 2893.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. Prohovnik, D. P. Perl, K. L. Davis, L. Libow, G. Lesser, and V. Haroutunian
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
Neurology, January 10, 2006; 66(1): 49 - 55.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Tiraboschi, L. A. Hansen, E. Masliah, M. Alford, L. J. Thal, and J. Corey-Bloom
Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease
Neurology, June 8, 2004; 62(11): 1977 - 1983.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Tiraboschi, M. N. Sabbagh, L. A. Hansen, D. P. Salmon, A. Merdes, A. Gamst, E. Masliah, M. Alford, L. J. Thal, and J. Corey-Bloom
Alzheimer disease without neocortical neurofibrillary tangles: "A second look"
Neurology, April 13, 2004; 62(7): 1141 - 1147.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Masliah, M. Alford, A. Adame, E. Rockenstein, D. Galasko, D. Salmon, L. A. Hansen, and L. J. Thal
A{beta}1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
Neurology, July 22, 2003; 61(2): 206 - 211.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
P. Tiraboschi, L. A. Hansen, M. Alford, A. Merdes, E. Masliah, L. J. Thal, and J. Corey-Bloom
Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease
Arch Gen Psychiatry, October 1, 2002; 59(10): 946 - 951.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Tiraboschi, L. A. Hansen, M. Alford, E. Masliah, L. J. Thal, and J. Corey-Bloom
The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease
Neurology, November 14, 2000; 55(9): 1278 - 1283.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. L. Foster, S. Minoshima, J. Johanns, R. Little, M. L. Heumann, D. E. Kuhl, and S. Gilman
PET measures of benzodiazepine receptors in progressive supranuclear palsy
Neurology, May 9, 2000; 54(9): 1768 - 1773.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Corey-Bloom, P. Tiraboschi, L. A. Hansen, M. Alford, B. Schoos, M. N. Sabbagh, E. Masliah, and L. J. Thal
E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease
Neurology, January 25, 2000; 54(2): 403 - 403.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. N. Sabbagh, J. Corey-Bloom, P. Tiraboschi, R. Thomas, E. Masliah, and L. J. Thal
Neurochemical Markers Do Not Correlate With Cognitive Decline in the Lewy Body Variant of Alzheimer Disease
Arch Neurol, December 1, 1999; 56(12): 1458 - 1461.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
N. Andreasen, C. Hesse, P. Davidsson, L. Minthon, A. Wallin, B. Winblad, H. Vanderstichele, E. Vanmechelen, and K. Blennow
Cerebrospinal Fluid {beta}-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease
Arch Neurol, June 1, 1999; 56(6): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. Berg, D. W. McKeel Jr, J. P. Miller, M. Storandt, E. H. Rubin, J. C. Morris, J. Baty, M. Coats, J. Norton, A. M. Goate, et al.
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Arch Neurol, March 1, 1998; 55(3): 326 - 335.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. G. M. Murphy, C. DeCarli, A. R. Mclntosh, E. Daly, M. J. Mentis, P. Pietrini, J. Szczepanik, M. B. Schapiro, C. L. Grady, B. Horwitz, et al.
Sex Differences in Human Brain Morphometry and Metabolism: An In Vivo Quantitative Magnetic Resonance Imaging and Positron Emission Tomography Study on the Effect of Aging
Arch Gen Psychiatry, July 1, 1996; 53(7): 585 - 594.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
A. Solodkin, S. D. Veldhuizen, and G. W. Van Hoesen
Contingent Vulnerability of Entorhinal Parvalbumin-Containing Neurons in Alzheimer''s Disease
J. Neurosci., May 15, 1996; 16(10): 3311 - 3321.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. Samuel, R. D. Terry, R. DeTeresa, N. Butters, and E. Masliah
Clinical Correlates of Cortical and Nucleus Basalis Pathology in Alzheimer Dementia
Arch Neurol, August 1, 1994; 51(8): 772 - 778.
[Abstract] [PDF]


Home page
Arch NeurolHome page
L. Berg, D. W. McKeel Jr, J. P. Miller, J. Baty, and J. C. Morris
Neuropathological Indexes of Alzheimer's Disease in Demented and Nondemented Persons Aged 80 Years and Older
Arch Neurol, April 1, 1993; 50(4): 349 - 358.
[Abstract] [PDF]


Home page
Arch NeurolHome page
E. V. Sullivan, P. K. Shear, D. H. Mathalon, K. O. Lim, J. A. Yesavage, J. R. Tinklenberg, and A. Pfefferbaum
Greater Abnormalities of Brain Cerebrospinal Fluid Volumes in Younger Than in Older Patients With Alzheimer's Disease
Arch Neurol, April 1, 1993; 50(4): 359 - 373.
[Abstract] [PDF]


Home page
Arch NeurolHome page
G. S. Smith, M. J. de Leon, A. E. George, A. Kluger, N. D. Volkow, T. McRae, J. Golomb, S. H. Ferris, B. Reisberg, J. Ciaravino, et al.
Topography of Cross-sectional and Longitudinal Glucose Metabolic Deficits in Alzheimer's Disease: Pathophysiologic Implications
Arch Neurol, November 1, 1992; 49(11): 1142 - 1150.
[Abstract] [PDF]


Home page
J Child NeurolHome page
O. Papazian
Topical Review Article: Transient Neonatal Myasthenia Gravis
J Child Neurol, April 1, 1992; 7(2): 135 - 141.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.